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Abstract Classic derivation of mouse embryonic stem
(ES) cells from blastocysts is inefficient, strain-dependent,
and requires expert skills. Over recent years, several major
improvements have greatly increased the success rate for
deriving mouse ES cell lines. The first improvement was
the establishment of a user-friendly and reproducible
medium-alternating protocol that allows isolation of ES
cells from C57BL/6 transgenic mice with efficiencies of up
to 75%. A recent report describes the use of this protocol in
combination with leukemia inhibitory factor and pluripotin
treatment, which made it possible to obtain ES cells from
F1 strains with high efficiency. We report modifications of
these protocols for user-friendly and reproducible deriva-
tion of mouse ES cells with efficiencies of up to 100%. Our
protocol involves a long initial incubation of primary
outgrowths from blastocysts with pluripotin, which results
in the formation of large spherical outgrowths. These
outgrowths are morphologically distinct from classical
inner cell mass (ICM) outgrowths and can be easily picked
and trypsinized. Pluripotin was omitted after the first
trypsinization because we found that it blocks attachment
of ES cells to the feeder layer and its removal facilitated
formation of ES cell colonies. The newly established ES
cells exhibited normal karyotypes and generated chimeras.
In summary, our user-friendly modified protocol allows
formation of large spherical ICM outgrowths in a robust
and reliable manner. These outgrowths gave rise to ES cell
lines with success rates of up to 100%.
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Introduction
Embryonic stem (ES) cells are capable of self renewal and
differentiation into all types of embryonic and adult cells,
including the germ-cell lineage. Mouse ES cells are usually
isolated from the inner cell mass (ICM) of blastocysts. The
first mouse ES cell lines were derived almost 30 years ago
[1, 2], but the classical way for isolating mouse ES cells is
very inefficient. It is highly dependent on the strain, and it
requires expert skills [3]. Several major improvements have
greatly increased the success rate for deriving mouse ES
cell lines. These improvements include the use of a defined
serum-free medium (knockout serum replacement, SR) [4],
alternating between ES cell media containing SR and fetal
bovine serum (FBS) [3], and the use of pharmacological
compounds [5–8]. In addition, mouse and rat ES cells could
be isolated and maintained in a chemically defined medium
containing three (3i) or two (2i) small-molecule inhibitors
and without the need for extrinsic stimuli, such as serum
factors, MEFs, LIF or BMP4 [9–11]. Pluripotin, a small
synthetic molecule, allows the propagation of mouse ES
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cells in an undifferentiated state in the absence of leukemia
inhibitory factor (LIF) and mouse embryonic fibroblasts
(MEFs) [12]. Finally, combining an SR/FBS medium
alternation protocol with the use of MEFs, LIF and
pluripotin made it possible to derive mouse ES cells from
F1 strains (C57BL/6 transgenics × CD1) with high
efficiency [13].
Bryja and colleagues developed a simple and user-
friendly protocol that allows investigators with basic cell
culture skills and standard equipment to derive ES cells [3].
However, the efficiency of their ES cell isolation protocol is
only about 50% [3]. Blastocysts were plated and grown for
6 days in SR-ES cell medium. Blastocyst outgrowths were
trypsinized and plated in FBS-ES cell medium and then
shifted back to SR-ES cell medium the following day. After
two more passages, alternating between ES cell media
containing SR and FBS, ES cell lines were established and
frozen. Yang and colleagues [13] modified this SR/FBS
medium alternation protocol in two ways. First, blastocysts
were plated and grown for 2 days in FBS-ES cell medium
followed by different incubation periods (1–12 days) in SR-
ES cell medium. Second, pluripotin was added to the ES
cell media during the first three passages. This procedure
allowed highly efficient derivation of ES cells [13].
We established a user-friendly and highly reproducible
pluripotin-based ES cell derivation protocol starting from
previously published protocols [3, 13]. By using our
modified procedure, we were able to isolate mouse ES cell
lines from wild-type C57BL/6 blastocysts as well as from
seven transgenic mouse strains with efficiencies of up to
100% (Table 1). This high success rate was reproduced
independently by two other researchers (Table 1). We
modified the previously published protocols [3, 13] by
culturing primary outgrowths from blastocysts for 12 days
in pluripotin-containing SR-ES cell medium and by
omitting pluripotin after the first trypsinization (Fig. 1).
Prolonged cultivation of primary outgrowths in the pres-
ence of pluripotin resulted in the formation of large spheres
composed of pluripotent cells that were morphologically
distinct from classical ICM outgrowths (Fig. 2, compare
panel a to b or c). These spheres were mostly loosely
attached to their substrate and often appeared in suspension;
in both cases, mouse ES cell lines could be readily isolated
from them. The large spherical outgrowths were easy to
pick, and after a single trypsinization step, they were
readily dissociated into single cells and plated on MEFs in
FBS-containing ES-cell medium. When pluripotin was
present in the FBS-containing ES cell medium, most of
the cells failed to attach to the MEF layer and were lost
when changing the medium to SR-containing ES cell
medium. In contrast, when the dissociated cells were
seeded in the absence of pluripotin, they attached readily
to the MEFs, and primary ES cell colonies were formed
efficiently within days. The loosely attached spherical
outgrowths facilitate the isolation of ES cells in several
ways. First, our protocol yields large outgrowths (300–
500 μm), containing several thousand cells. This provides a
lot of starting material before the first trypsinization. In
contrast, the outgrowths obtained according to published
reports are much smaller (100 μm) [3, 13]. Second, the
spherical outgrowths (obtained by our protocol) are loosely
attached to the MEFs and are easy to pick and trypsinize. In
contrast, the primary outgrowths obtained by the protocol
of Yang and colleagues are strongly attached to the feeder
layer and are difficult to pick [13]. In addition, these
outgrowths are hard to dissociate and require an additional
collagenase IV treatment [13]. Other differences between
our ES cell procedure and previously published protocols
are listed in Table 2.
In conclusion, our pluripotin-based protocol is user-
friendly and very efficient (with success rates of up to
100%) and could make stem cell research feasible for a
broader scientific community. In addition, it can generate
both transgenic and littermate control ES cell lines, which
Table 1 The derivation efficiency of ES cells from blastocysts
Strain/mating Background No. of blastocysts Primary outgrowth (passage 0) Lines derived (>passage 5)
C57BL/6 – 6 6 (100%) 6 (100%)a
ROSA26 reporter x C57BL/6 C57BL/6 6 6 (100%) 6 (100%)a
p120ctnKOC/+ intercross C57BL/6 9 7 (78%) 6 (67%)
p120ctnKIC/+ intercross C57BL/6 20 18 (90%) 18 (90%)
p120ctn+/− intercross B6/129/CD1 5 5 (100%) 5 (100%)
p120ctnKOC/+ x p120ctn+/− B6/129/CD1 13 13 (100%) 13 (100%)
p120ctnKIC/+ x p120ctn+/− B6/129/CD1 8 8 (100%) 8 (100%)
ROSA26-antiLuc B6/129/Swiss 16 16 (100%) 16 (100%)b
Total 83 79 (95%) 78 (94%)
a ES cell isolation performed by T.H.
b ES cell isolation performed by L.H.; B6: C57BL/6
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allows stem cell characterization and subsequent differen-
tiation experiments to be set up with minimal genetic
variation.
Materials
Collecting Blastocysts and Morulas
1. Mice (Note 1)
2. Sterile dissection tools (fine scissors and forceps for
dissecting out the uterus and oviduct)
3. M2 medium (Sigma-Aldrich, St. Louis, MO)
4. Fine forceps (Dumont #5 Standard tip Student
forceps, Fine Science Tools, Heidelberg, Germany)
5. A blunt 32G needle (Popper & Sons Inc., New York,
Cat. No. 7400)
6. A 5-ml Luer-Lok syringe
7. A 23G needle
8. A 1-ml syringe
9. Tyrode solution (Sigma-Aldrich)
10. 1.5-ml tubes
11. 60-mm bacterial grade plates (for flushing)
12. Mouth pipette (Note 2)
13. Access to a stereo microscope with transmitted-light
base.
14. Access to a laminar air flow
Pluripotin-based ES Cell Isolation
1. Mouse embryonic fibroblasts (MEFs, TgN (DR4)1
Jae strain)
2. Mitomycin C (Sigma-Aldrich)
3. Phosphate buffered saline (PBS) without calcium or
magnesium (Gibco, Grand Island, NY)
4. 0.1% Gelatin (Sigma-Aldrich) (Note 3)
5. MEF medium: Dulbecco’s modified Eagle’s medium
(DMEM, Gibco), 10% fetal bovine serum (FBS)
(Sigma-Aldrich), L-glutamine (2 mM, Gibco), Sodi-
um puryvate (0.4 mM, Gibco), penicillin (100 U/ml,
Gibco), streptomycin (100 mg/ml, Gibco).
6. SR-ES cell medium: DMEM (Gibco) and F12 (Gibco)
mixed in a 1:1 ratio and supplemented with 15%
knock-out serum replacement (SR, Gibco, Cat. No.
10828–028), L-glutamine (2 mM, Gibco), penicillin
(100 U/ml, Gibco), streptomycin (100 mg/ml, Gibco),
β-mercaptoethanol (0.1 mM, Gibco), and 2,000 U/ml
recombinant mouse LIF (DMBR/VIB Protein Service
facility, www.dmbr.ugent.be).
7. FBS-ES cell medium: Similar to SR-ES cell medium
but 15% SR is replaced by 15% FBS (Hyclone,
Logan, UT, Cat. No. SH30070.03E).
8. Pluripotin (Cayman Chemical, Ann Arbor, MI) (Note 4)
9. Mouth pipette (Note 2)
10. Trypsin (0.25%) (Gibco)
11. Sterile pipettes: 5 ml, 10 ml and 25 ml
12. 15-ml conical centrifuge tubes
13. 96-well culture plates (curved bottom and flat bottom)
14. Culture dishes: 24 wells, 12 wells and 6 wells
15. Multichannel pipettes (to pipette 30, 50, 100 and 200 μl)
16. Sterile multichannel reservoirs
17. Access to a laminar air flow
18. Access to an incubator at 37°C with 5% CO2
19. Access to an inverted microscope
20. Access to a bench-top centrifuge
21. Access to a stereo microscope with transmitted-light
base
Fig. 1 Scheme of ES cell derivation with LIF and pluripotin.
Blastocysts are flushed on day 1 and seeded in 12-well plates coated
with MEFs and containing pluripotin-supplemented SR-ES cell
medium (15% SR). Small spherical colonies, observed on day 6,
grow rapidly to form large spherical cell aggregates that are loosely
attached to the substrate on day 12. Large pluripotent cell aggregates
are trypsinized with 0.25% trypsin and seeded in 96-well plates
containing MEFs and FBS-ES cell medium (15% FBS) but no
pluripotin. The next day, FBS-ES cell medium is replaced with SR-ES
cell medium. ES cells appear after further incubation. Newly
established ES cell colonies are passaged three more times, changing
the medium from FBS to SR-ES and scaling up from 96-well to 24-
well and then 6-well plates. On about day 24, a confluent 6-well plate
of the newly established mouse ES cell line can be frozen. Modified
after [3]
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Methods
Collecting Blastocysts and Morulas
1. Set up time matings: Female mice (can be super-
ovulated) at the age of 6–16 weeks are housed with
male studs. Check for copulation plugs the following
morning. Plugged females are considered to be carrying
0.5 dpc (days post coitum) embryos.
2. Sacrifice pregnant females to collect blastocysts
(3.5 dpc) or morulas (2.5 dpc). Make a midventral
incision and dissect from both sides a piece that
consists of the uterus and the oviduct. A first cut is
made in the uterus just before the cervix and a second
cut is made between the ovary and the oviduct.
Transfer the excised pieces to a 1.5-ml tube containing
500 μl M2 medium. Dissection should be done in a
laminar air flow.
3. In a laminar air flow, transfer the uteri to bacterial grade
dishes and locate the oviduct under the stereo micro-
scope using fine forceps. The flushing procedure differs
depending on whether blastocysts (4a) or morulas (4b)
are to be collected.
4a. Flush blastocysts (3.5 dpc) from the uterus with a 23G
needle and a 1-ml syringe filled with M2 medium.
Bend the 23G needle approximately 45° and insert the
needle in the end of the uterus that is closest to the
oviduct. Hold the needle in place with fine forceps
while pressing the plunger. Swelling of the uterus
indicates successful flushing and can be monitored
under the microscope.
4b. Flush morulas (2.5 dpc) from the oviduct with a blunt
32G needle and a 5-ml Luer-Lok syringe filled with
M2 medium. Flushing morulas from oviducts is
difficult and requires technical skill. Locate the
infundibulum, the funnel-shaped end of the oviduct
that is nearest to the ovary. Insert the needle in the
infundibulum and the first part of the oviduct and
flush while holding the needle in place with fine
forceps.
5. Using a mouth pipette, collect all embryos and
transfer them to a drop (approximately 250 μl) of
M2 medium. Wash embryos two more times by
transferring them twice to a fresh drop of M2
medium.
6. Remove the zona pellucida from morulas by treating
them with Tyrode solution (Note 5).
Fig. 2 Formation of non-classical spherical ICM outgrowths in
SR medium supplemented with pluripotin and LIF. Formation of
ICM outgrowths from wild-type C57BL/6 blastocysts under
different experimental conditions. a Two examples of non-
classical, loosely attached, spherical ICM outgrowths formed after
incubation in SR-ES medium supplemented with pluripotin and
LIF. Outgrowths were plated in 12-well plates with (top) or without
MEFs (bottom). b Omitting pluripotin from the SR medium in the
first 2 days allows attachment of blastocysts and formation of flat
ICM outgrowths, which persist after pluripotin administration. Two
examples are shown. c Two examples of ICM outgrowths formed
by using a previously reported protocol [13]. Blastocysts were
incubated for 2 days (2 d) in FBS-ES medium supplemented with
pluripotin and LIF, followed by incubation in SR-ES medium
supplemented with pluripotin and LIF. DIV: days in vitro. Scale bar:
100 μm
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Pluripotin-based ES Cell Isolation (Fig. 1)
1. a) Prepare gelatinized 12-well plates (1 well/embryo,
Note 3) with mitomycin-C-treated MEFs (Note 6)
1 day before the embryos are collected. b) Change
medium from MEF to SR-ES cells medium (2 ml/
well) with pluripotin (2 μM, Note 4) 1 h before the
embryos are collected (Note 7). Incubate at 37°C in
5% CO2 (Note 8).
2. Plate blastocysts and morulas individually in 12-well
plates using a mouth pipette. Monitor the proper
distribution of embryos under a stereo microscope
(inside a laminar air flow).
3. Refresh the pluripotin-containing SR-ES cell medium
every 2–3 days by using a mouth pipette (Note 9).
4. a) Prepare a gelatinized 96-well plate (flat bottom, 1
well/outgrowth) with mitomycin-C-treated MEFs and
MEF medium (200 μl/well) 1 day before the
trypsinization of spherical ICM outgrowths. b)
Change medium from MEF to FBS-ES cell medium
without pluripotin 1 h before dissociated blastocyst
outgrowths are plated. Omit pluripotin from this point
on (Note 10).
5. Dispense sterile PBS in a 96-well curved bottom plate
(30 μl/well, 1 well/outgrowth).
6. Pick the large, loosely attached spherical outgrowths
between day 12 and 18 (Note 11) using a pipette with
a 10-μl tip. Locate outgrowths under the stereo
microscope (inside a laminar air flow) and transfer
each outgrowth in approximately 5 μl medium to a
separate PBS-filled well in the 96-well plate. Use a
different tip for each outgrowth. If an entire row in the
96-well plate is filled (12 outgrowths), proceed to step
7. Check that all outgrowths are successfully trans-
ferred to the 96-well plate before trypsinization.
7. Add 50 μl of 0.25% trypsin to each well using a
multichannel pipette and incubate for 3 min at 37°C in
5% CO2 (Note 12). Trypsinize only 12 outgrowths
(one row) at a time.
8. Add 100 μl FBS-ES cell medium (from the flat-
bottomed 96-well plate) to each well using a multi-
channel pipette. Dissociate outgrowths into single
cells and small cell clumps by pipetting 10–15 times.
Transfer dissociated cells to the 96-well mitomycin-C-
treated MEF plate (flat bottom).
9. Next day, change medium from FBS-ES to SR-ES cell
medium.
10. After 1–2 days of growth in SR-ES cell medium
(refresh every day), the newly established ES cell
colonies can be passaged to 24-well plates (Note 13).
For that, prepare gelatinized 24-well plates (1 well/ES
cell line) with mitomycin-C-treated MEFs and MEF
medium (1 ml/well) 1 day in advance. Change
medium from MEF to FBS-ES cell medium 1 h
before the next step (trypsinization).
11. Wash the ES cell colonies (from the 96-well plate) with
PBS. Add 30 μl of 0.25% trypsin to each well (in the 96-
well plate) and incubate for 3 min at 37°C in 5% CO2.
12. Add 100 μl FBS-ES cell medium to each well,
dissociate ES cell colonies into single cells by
pipetting 10–15 times. Transfer dissociated cells to
24-well mitomycin-C-treated MEF plates.
13. Next day, change medium from FBS-ES to SR-ES cell
medium.
14. After 1–2 days of growth in SR-ES cell medium
(refresh every day), the ES cell lines can be passaged
Table 2 Comparison of different ES cell derivation protocols
ES cell derivation protocol
Classical Byrja et al. [3] Yang et al. [13] This report
Blastocysts seeded in FBS-medium SR-medium FBS-medium SR-medium
Incubation time of primary
outgrowths
4–5 days 6 days 3–14 days 12 days
Alternation of medium No Yes Yes Yes
Pluripotin treatment/
concentration
No No 3–5 μM until the third passage 2 μM until first trypsinization
Morphology of the
outgrowth
ICM-like colony ICM-like colony ICM-like colony big spheres
Attachment of outgrowths
to feeders
Strong Strong Strong Weak
Size of outgrowths 100 μm 300–500 μm
Outgrowth dissociation Trypsin Trypsin Collagenase IV, trypsin Trypsin
User-friendly No Yes No Yes
Success rate (strain) 30% (129) 10% (B6) 50–75% (B6 transgenics) 100% (F1: B6 transgenics X CD1) 100% (B6 transgenics)
FBS fetal bovine serum; SR serum replacement; B6: C57BL/6
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to three wells in a 24-well plate (Fig. 1). For that,
repeat step 10.
15. Repeat step 11 by adding 200 μl of 0.25% trypsin to
each well in the 24-well plate.
16. Fill a plastic pipette with 6 ml MEF medium,
dissociate ES cell colonies into single cells by
pipetting, and transfer the cell suspension to a 15-ml
centrifuge tube. Centrifuge 5 min at 1,000 rpm.
Aspirate and discard the medium.
17. Resuspend the pellet in 3 ml FBS-ES cell medium and
distribute in three wells of a 24-well plate (Note 14).
18. Next day, change medium from FBS-ES to SR-ES cell
medium.
19. After 1–2 days of growth in SR-ES cell medium
(refresh every day) the ES cells can be passaged to 6-
well plates. For that, prepare gelatinized 6-well plates
(1 well/ES cell line) with mitomycin-C-treated MEFs
(similar to what is described in step 10).
20. Repeat step 11 by adding 200 μl of 0.25% trypsin to
each well in the 24-well plate.
21. Repeat step 16.
22. Resuspend the pellet in 1 ml FBS-ES cell medium and
put it in a well (of a 6-well plate) that contains MEFs
and 1 ml of FBS-ES cell medium.
23. Next day, change medium from FBS-ES to SR-ES cell
medium.
24. After 1–2 days of growth in SR-ES cell medium
(refresh every day), three freezings can be made from
one 70% confluent well (of a 6-well plate) using
standard freezing techniques (Note 15).
25. Established ES cell lines can be propagated further
using SR-ES medium (or other ES cell media; refresh
every day). Split ES cells 1/4 or 1/5 every 2–3 days.
Established ES cell lines were validated (Note 16),
generated chimeras (Note 17) and displayed a normal
mitotic karyotype (Note 18).
26. Expected results: ES cells can be isolated from
blastocysts with this protocol with an efficiency of
up to 100% (Table 1) (Note 19). In comparison with
previous reported protocols our method is robust and
user-friendly (Note 20).
Notes
1. Mice were housed in individually ventilated cages in a
specific-pathogen-free animal facility. All experiments
on mice were conducted according to institutional,
national, and European animal regulations. Animal
protocols were approved by the ethics committee of
Ghent University. The generation of p120ctnKOC/+ and
p120ctnKIC/+ mice, both on a C57BL/6 background,
will be reported elsewhere (Pieters et al., in prepara-
tion). ROSA26 reporter (R26R) mice [14] were
backcrossed to C57BL/6. The ROSA26-antiLuc re-
porter mice were generated by homologous recombi-
nation in G4 ES cells [15] using the ROSA26-antiLuc
construct obtained from the laboratory of Dr. Dagmar
Wirth [16]. B6/129 ROSA26-antiLuc F1-hybrid mice
were subsequently outbred and maintained on a mixed
B6/129/Swiss background. The p120ctn null allele
was generated by Cre-mediated removal of a floxed
region in the p120ctn gene (containing exons 3–8)
[17, 18].
2. A mouth pipette consists of a micropipette, a
micropipette holder, tubing and an aspirator mouth
piece. For detail, see Nagy et al., [19]. Micropipettes
can be custom made by heating the finest part of a
Pasteur pipette for a few seconds in the flame of a
Bunsen burner, removing the pipette from the flame,
and pulling both ends. The procedure can be repeated
several times until a needle with a diameter slightly
larger than a blastocyst is obtained (100–200 μm).
3. All culture plates or dishes have to be coated with
0.1% gelatin. Dissolve 0.5 g in 500 ml distilled water,
autoclave and store at 4°C. Before seeding the MEFs,
add 0.1% gelatin to the culture plates, incubate 5 min
at 37°C in 5% CO2 and aspirate the gelatin solution.
4. Dissolve 5 mg pluripotin in 2.27 ml DMSO (4 mM,
2000X stock) and store aliquots at −20°C. Add
pluripotin to the medium just before use (final
concentration: 2 μM).
5. Prepare a bacterial grade plate with several drops
(250 μl) of M2 medium and Tyrode solution. Transfer
up to five embryos to a drop of Tyrode solution by
mouth pipetting and monitor the deterioration of the
zona pellucida under the microscope. When the zona
starts to deteriorate, quickly transfer the embryo to a
drop of M2 medium (exposure of zona-free embryos
to Tyrode solution may harm them). Remains of the
zona pellucida can be removed mechanically by
pipetting the embryo several times up and down using
a mouth pipette. Transfer embryos freed from their
zona pellucida to a fresh drop of M2 medium (make
sure there are no traces of Tyrode solution left in the
needle of the mouth pipette).
6. Detailed protocols to isolate MEFs have been reported
elsewhere [20, 21]. In brief, collect E13.5 embryos,
remove the head and internal organs, and trypsinize
the embryonal tissue. Dissociate the tissue into single
cells and plate and grow them in MEF medium on
gelatinized plates. Two embryos provide sufficient
cells for one 15-cm culture dish. Confluent MEF
plates can be frozen immediately (passage 0) or
expanded two times before freezing (passage 2). One
vial of passage-2 MEFs, frozen from a confluent 15-
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cm dish, can be divided over three to four gelatinized
culture plates (6-, 12-, 24-, or 96-well) or over three to
four gelatinized 10-cm culture dishes. After 2–3 days
the MEFs reach confluency and can be inactivated by
treating them with Mitomycin C (10 μg/ml) for 3 h.
Two milligrams of Mitomycin C is dissolved in 2 ml
sterile PBS. This 100X stock can be stored at 4°C.
Mitomycin C-inactivated MEFs should be washed at
least three times before use.
7. Blastocysts are plated in gelatinized 12-well plates
with mitomycin-C-treated MEFs (Fig. 2a, top). How-
ever, SR-ES cell medium that is supplemented with
pluripotin is harmful to the MEF cells and it is not
unusual that half of the MEF cells die during the first
week. Nevertheless, this massive death of MEF cells
does not affect the ES cell isolation efficiency. In
contrast, if blastocysts were plated in uncoated 12-
well plates without MEFs (Fig. 2a, bottom), they did
not always form big spherical outgrowths and the
success rate for isolation ES cells dropped to 40% (8
ES cell lines form 20 blastocysts). In addition, it has
been reported that MEFs, unlike ES cells, do not
adhere to gelatin-coated dishes in the presence of SR-
ES cell medium (Gibco, data sheet Cat. No. 10828).
Therefore, MEFs should always be seeded in MEF
medium. This MEF medium is replaced by FBS-ES
cell medium 1 h before trypsinization.
8. MEFs, primary outgrowths and ES cells are grown at
37°C with 5% CO2.
9. Incubation of primary outgrowths in the presence of
SR-ES cell medium and pluripotin results in the
formation of big spheres that do not much resemble
the classical ICM outgrowths (Fig. 2, compare panel a
to b or c). These spheres are mostly loosely attached
to the MEFs and often appear in suspension. In
contrast to classic ICM outgrowths that stick to the
MEFs, the loose spherical outgrowths can be lost
when the medium is aspirated. Indeed, in our hands
the efficiency of initial mouse ES cell isolations (using
our protocol) was not maximal due to the loss of non-
attached spheres while changing medium. Therefore,
loose outgrowths should be transferred to an empty
well filled with SR-ES cell medium using a mouth
pipette and then transferred back once the medium is
refreshed. The medium of outgrowths sticking to the
feeder layer can either be refreshed as such or the
outgrowths are picked and transferred using a mouth
pipette as mentioned above; we recommend using a
mouth pipette. Culturing blastocysts the first 2 days
without pluripotin resulted in the formation of flat ICM
outgrowths, which stay firmly attached to the underlying
feeder and trophectoderm layer after pluripotin admin-
istration (Fig. 2b). However, these flat ICM outgrowths
are harder to pick and trypsinize and are less efficient
(33%) in establishing ES cell lines.
10. When pluripotin was present in the FBS-containing
ES cell medium, most of the cells failed to attach to
the MEF layer and were lost when changing the
medium to SR-containing ES cell medium. In con-
trast, when cells dissociated after the first trypsiniza-
tion were seeded in the absence of pluripotin, they
readily attached to the MEFs, and primary ES cell
colonies were formed efficiently within days.
11. The primary outgrowth should have a diameter of about
300 μm at the time of trypsinization. Blastocyst out-
growths can be cultured for up to 18 days without losing
their ability to form ES cell lines. The main advantage of
a long initial cultivation in pluripotin-containing SR-ES
cell medium is that it allows a large number of
undifferentiated cells to develop before the first trypsi-
nization. Apparently, the establishment of ES cell lines
became more reliable once large pluripotent spheres
were obtained: 79 initial outgrowths gave rise to 78 ES
cell lines (99%). In addition, using a transgenic Oct4-
EGFP line (EGFP driven by the Oct4-promoter), Yang
and colleagues [13] showed that outgrowths from Oct4-
EGFP blastocysts expressed EGFP for up to 14 days.
Smaller outgrowths can also give rise to ES cell lines
but they generate fewer colonies, which have to be
cultured for longer times before they can be passaged.
12. The outgrowths are readily dissociated into single
cells in a single trypsinization step. Sequential
digestion, as suggested by Yang and colleagues [13],
is not required.
13. If a well of the 96-well plate contains only a few ES
cell colonies, it is better to let these colonies grow for
a few more days, and trypsinize (step 11) and plate
them again in a new well of a 96-well mitomycin-C-
treated MEF plate (flat bottom, containing FBS-ES
cell medium). Next day, change medium to SR-ES
cell medium. Wait for ES cell colonies to appear and
proceed again to step 11.
14. At this stage you can decide to make a freezing (Note
15) and/or a DNA preparation. For a DNA prepara-
tion, transfer one third of the ES cells (1/3 of a 24-
well) to gelatinized 24-well plates (without MEFs).
After 30 min, transfer the cell suspension to a new
well to get rid of most of the MEFs, which would
otherwise contaminate the DNA preparation. MEFs
attach faster than ES cells to gelatinized plates.
Genomic DNA is prepared from confluent wells
according to Laird et al. [22]. Alternatively, you can
speed up the ES cell isolation by transferring ES cells
from two wells (of a 24-well plate) to a 6-well plate.
15. Our freezing method: ES cells (70% confluent) from a
6-well plate are trypsinized (800 μl), dissociated and
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centrifuged. The cell pellet is resuspended in 10%
DMSO and 90% FCS (1 ml/freezing). Cells are placed
on ice for 30 min and frozen at −80°C. Frozen cells
are kept at −80°C for up to several weeks and in liquid
nitrogen for long time storage.
16. The newly established ES cell lines could be
maintained in a morphologically undifferentiated
state for over 10 passages (Fig. 3a), they expressed
the transcription factor Oct-4 (Fig. 3b), and they
readily formed embryoid bodies (EBs, Fig. 3c).
Those EBs could be differentiated into various cell
types (Fig. 4d), including neurectoderm (Nestin),
mesoderm (Smooth muscle actin), skeletal muscle
(α-Dystrobrevin), beating cardiomyocytes (Tropo-
nin), and endothelial and hematopoietic cell types
(data not shown). The procedure for forming
embryoid bodies was similar to that described before
[23, 24]. In brief, ES cells were feeder-depleted and
Fig. 3 Properties of ES cell
lines derived from pluripotin-
treated primary outgrowths. a
Morphology of newly estab-
lished mouse ES cell lines.
White scale bars: 200 μm, black
scale bars: 100 μm. b ES cells
are positive for stem cell marker
Oct-4. Scale bars: 25 μm. c ES
cells form embryoid bodies
(EBs) after 10 days of culture in
suspension. Scale bars: 200 μm.
d Marker analysis after random
in vitro differentiation of ES
cells. EBs (from c) were plated
on gelatinized culture dishes and
allowed to attach and spread out
for another 10 days in order to
differentiate into various cell
types, including neurectoderm
(Nestin), mesoderm (Smooth
muscle actin), skeletal muscle
(α-Dystrobrevin) and beating
cardiomyocytes (Troponin).
Scale bars: 50 μm. e Chimeras
generated from ROSA26-
AntiLuc and p120ctn+/− ES cells
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passaged once on gelatinized plates. For random
differentiation into EBs, ES cells were plated in
different dilutions unto bacterial grade Petri-dishes
in differentiation medium (IMDM medium (Invitro-
gen) supplemented with 15% FBS (Hyclone), 5%
PFMHII (Invitrogen), 2 mM L-glutamine (Invitro-
gen), 0.4 mM MTG (Sigma), 50 μg/ml ascorbic acid
(Sigma) and penicillin (100 U/ml)-streptomycin
(100 μg/ml) (Invitrogen). EBs were allowed to form
in these dishes for 10 days. The EBs were then
plated unto gelatinized culture dishes and allowed to
attach and spread out for 10 days in differentiation
medium. The staining procedure for ES cells and
plated EBs involved fixation with 4% paraformal-
dehyde, permeabilization with 0.2% TX-100 and
incubation at room temperature for 2 h with primary
antibody and 1 h with secondary antibody (Molec-
ular Probes, Eugene, OR). The following primary
antibodies were used: mouse monoclonal anti-Oct-4
(1/100, Santa Cruz Biotechnology, Santa Cruz, CA),
mouse monoclonal anti-Nestin (1/100, Becton Dick-
inson, New York), mouse mocolonal anti-Smooth
muscle actin (SMA, 1/100, Sigma), mouse mono-
clonal anti-Troponin (1/100, Thermo Scientific,
Wal tham, MA), rabbi t polyc lonal ant i -α -
Dystrobrevin (1/200, H-300, Santa Cruz). Confocal
microscopy was performed using a Leica TCS SP5
confocal scan head attached to a Leica DM IRE2
inverted microscope and a PC running Leica AF
software version 2.5.
17. Chimeras were generated from different pluripotin-
derived ES cells (Fig. 3e). ROSA-antiLuc ES cell
lines generated weak chimeras, probably because
these ES cells exhibited significant chromosomal
instability as they were derived with 4 μM pluripotin
(Note 18). p120ctn+/− ES cells derived with 2 μM
pluripotin generated strong chimeras. Chimeras were
generated by diploid aggregation. Briefly, embryos
were collected on day E2.5 from superovulated
Swiss female mice. Zona pellucida of embryos was
removed by treatment with acid Tyrode’s solution
(Note 5, Sigma). ES cell colonies were briefly
Fig. 4 Chromosomal analysis
of pluripotin-derived ES cells a
Fluorescent image of a DAPI-
stained mitotic spread from a
mouse ES cell line, depicting 40
acrocentric chromosomes. Scale
bar: 5 μm. b–c Graphs depicting
the percentage of mitotic
spreads that contain 39, 40, 41,
42 and 43 or more chromo-
somes. Mitotic spreads from 10
ES cell lines derived with 4 μM
(b) or 2 μM (c) pluripotin were
analyzed. An ES cell line is
considered normal if 70% or
more of its spreads contain 40
chromosomes. All ES cell lines
derived with 4 μM pluripotin
showed chromosomal instabili-
ty, whereas most ES cell lines
derived with 2 μM pluripotin
exhibited a normal karyotype
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treated with 0.25% trypsin-EDTA (Invitrogen) to
form loosely connected clumps of 7–10 cells. Each
zona-free embryo was aggregated with a clump of
7–10 cells inside depression wells made in a 35-mm
plastic dish (VWR International) with an aggrega-
tion needle (BLS Ltd, Hungary). They were cultured
overnight in microdrops of KSOM with amino acids
(Biognost) under mineral oil (Sigma) at 37°C in 95%
air/5% CO2. The next day, blastocysts were trans-
ferred into the uteri of 2.5-dpc pseudopregnant
Swiss females previously mated with vasectomized
males. Chimeras were identified at birth by the
presence of black eyes and later by agouti coat
pigmentation.
18. Normal mitotic karyotype of mouse ES cells
consists of 40 acrocentric chromosomes (Fig. 4a).
Chromosomal analysis was performed on 10 ES cell
lines derived with 4 μM pluripotin. Chromosomal
instability was observed in all of them (Fig. 4b).
Thus, these lines are only suitable for in vitro
analysis. In contrast, ES-cell lines derived with
2 μM pluripotin during the blastocyst outgrowth
phase were generated with high efficiency (100%)
and these lines had a normal karyotype (Fig. 4c). In
addition, strong chimeras could be derived from
these ES cell lines. Yang and colleagues [13] derived
ES cells with 3–5 μM pluripotin. Their ES cells
showed some chromosomal abnormalities and were
not proven to be germline competent [13]. By
lowering the pluripotin concentration from 4 to
2 μM, we obtained ES cells that generated strong
chimeras and displayed a normal karyotype. To make
mitotic spreads for counting chromosomes, ES cells
were passaged to gelatinized six-well plates. Nearly
confluent ES cell cultures were grown for 2 h with
demecolcine (50 ng/ml, Sigma), washed with PBS,
and trypsinized. Resuspended ES cells were incubat-
ed 15–20 min in warm KCl solution (75 mM) and
washed four times with freshly-made cold fixative
consisting of a 3:1 mixture of methanol and glacial
acetic acid. ES cells were resuspended in 500 μl
fixative and dispersed on three wet slides (80 μl/
slide) (SuperFrost Plus microscope slides, Klinipath).
Air-dried slides were stained with DAPI and 20
individual spreads were counted. Spreads with 38
chromosomes or less were discarded. An ES cell line
is considered normal if 70% or more of its spreads
contain 40 chromosomes.
19. Isolation of ES cells from morulas turned out to be
much less efficient (Table 3) due to decreased
formation of primary outgrowths (32% compared to
95%).
20. Differences between our protocol and that of Yang
et al. [13] are listed in Table 2. We also compared
the performance of our modified mouse ES cell
derivation protocol with other protocols, including
the one published by Yang and colleagues [13].
From the nine wild-type C57BL/6 blastocysts that
we processed with Yang’s protocol, only five formed
small ICM outgrowths (Fig. 2c; top, DIV 10). Most
outgrowths spontaneously dissociated after 10 days
of culture (Fig. 2c; bottom, DIV 10) and no ES cell
lines could be derived from them. In contrast, all six
wild-type C57BL/6 blastocysts processed according
to our modified protocol formed large spherical ICM
outgrowths after 10 days of culture (Fig. 2a, DIV
10). ES cell lines could be established for all six
outgrowths (Table 1). Remarkably, the two
pluripotin-based protocols gave rise to morphologi-
cally different ICM outgrowths. This discrepancy
between our results and those of Yang and col-
leagues [13] might have been due to the use of
different ES cell media in which blastocysts are
seeded. On the first 2 days, Yang and colleagues
[13] used FBS-ES cell medium (Table 2), which
might contain factors that stimulate attachment of
blastocyst outgrowths to the substrate in the pres-
ence of pluripotin. These factors are probably not
present in the chemically defined SR-ES cell
medium that we used. On the other hand, seeding
blastocysts in SR-ES cell medium alone allows
attachment of the outgrowths to the MEFs and the
formation of flat ICM outgrowths (Fig. 2b). Our data
indicate that pluripotin, at least in SR-ES cell
medium, blocks the attachment of outgrowths to
the MEFs. Such a block might promote growth and
result in the formation of bigger but loosely attached
outgrowths.
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